InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
8
T+90 hit rate
25%
T+90 mean return
-26.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Hariri Robert J, Chief Executive Officer. Director active across 4 companies, notably Celularity Inc. Cumulatively, 28 disclosures have been recorded. Breakdown: 4 buys · 8 sells. Total volume traded: €1.8m. Activity tracked since 29 April 2022. The latest transaction was filed on 13 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations28 total
3,281 shares0Class A Common StockSEC:0001493152-26-016832
3,281 shares0Class A Common StockSEC:0001493152-26-016832:0
12,500 shares@ US$6.1029.6% of flowCommon StockSEC:0001104659-25-055047:0
3,281 shares0Class A Common StockSEC:0001641172-25-004823:0
1,154 shares@ US$1.640.0% of flowClass A Common StockSEC:0001641172-25-004823:1
2,500 shares@ US$6.486.7% of flowCommon StockSEC:0001104659-24-124748:0
1,000 shares@ US$9.4653.7% of flowCommon StockSEC:0001104659-24-092969:0
1,000 shares@ US$8.39543.3% of flowCommon StockSEC:0001104659-24-091339:0
12,845 shares0Common StockSEC:0001104659-24-063964:0
1,154 shares@ US$4.110.1% of flowClass A Common StockSEC:0001493152-24-014947:0
800 shares@ US$16.895.4% of flowCommon StockSEC:0001104659-23-127005:0
1,000 shares@ US$15.506.3% of flowCommon StockSEC:0001104659-23-125791:0
42,254 shares0Common StockSEC:0001520138-23-000532:0
9,064,539 shares@ US$0.165540.2% of flowClass A Common StockSEC:0000950170-23-052758:0
Ideal exit: 25 Jun 2024 (T+270)
1,500 shares@ US$13.608.3% of flowCommon StockSEC:0001104659-23-100116:0
8,105 shares0Common StockSEC:0001104659-23-061520:0
11,540 shares@ US$0.71410.2% of flowClass A Common StockSEC:0000899243-23-011343:0
2,084,854 shares@ US$0.834345.5% of flowClass A Common StockSEC:0000950170-23-010087:0
34,240 shares0COMMON STOCKSEC:0001520138-23-000057:0
10,000 shares@ US$1.71750.5% of flowClass A Common StockSEC:0000899243-22-037241:0
Ideal exit: 27 Aug 2023 (T+270)
40,000 shares@ US$1.711.9% of flowClass A Common StockSEC:0000899243-22-037162:0
Ideal exit: 26 Aug 2023 (T+270)
40,000 shares@ US$1.741.9% of flowClass A Common StockSEC:0000899243-22-037102:0
Ideal exit: 25 Aug 2023 (T+270)
119,073 shares@ US$2.879.7% of flowClass A Common StockSEC:0000899243-22-029784:0
2,000 shares@ US$43.290736.6% of flowCommon StockSEC:0001104659-22-091871:0
7,203 shares0Common StockSEC:0001104659-22-055438:0
25 of 28 declarations
About Hariri Robert J
Robert J. Hariri is the Chief Executive Officer of Celularity Inc. and Cryoport, Inc. He is responsible for the strategic direction of the companies, which specialize in cellular therapies and logistics solutions for biological products. Mr. Hariri plays a crucial role in setting growth objectives and overseeing daily operations.
